{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:13:17Z","timestamp":1756462397650},"reference-count":44,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81202366","81271892","U1302224","U0832601"],"award-info":[{"award-number":["81202366","81271892","U1302224","U0832601"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Knowledge Innovation Program of the Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["KSCX2-EW-R-12","KJZD-EW-L10-02"],"award-info":[{"award-number":["KSCX2-EW-R-12","KJZD-EW-L10-02"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Yunnan Applicative and Basic Research Program","award":["2013FB073"],"award-info":[{"award-number":["2013FB073"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.micinf.2017.01.002","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T07:45:15Z","timestamp":1484552715000},"page":"288-294","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Heroin use is associated with lower levels of restriction factors and type I interferon expression and facilitates HIV-1 replication"],"prefix":"10.1016","volume":"19","author":[{"given":"Jia-Wu","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De-Yao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Tang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2017.01.002_bib1","series-title":"Global report: UNAIDS report on the global AIDS epidemic 2013","author":"UNAIDS","year":"2013"},{"key":"10.1016\/j.micinf.2017.01.002_bib2","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/add.13348","article-title":"Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality","volume":"111","author":"Suarez-Garcia","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.micinf.2017.01.002_bib3","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1360-0443.1997.tb02867.x","article-title":"Young and recent-onset injecting drug users are at higher risk for HIV","volume":"92","author":"Fennema","year":"1997","journal-title":"Addiction"},{"key":"10.1016\/j.micinf.2017.01.002_bib4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0140-6736(10)60829-X","article-title":"Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs","volume":"376","author":"Altice","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2017.01.002_bib5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00002030-199403000-00007","article-title":"Continued drug use and other cofactors for progression to AIDS among injecting drug users","volume":"8","author":"Ronald","year":"1994","journal-title":"AIDS"},{"key":"10.1016\/j.micinf.2017.01.002_bib6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/CMR.16.2.209-219.2003","article-title":"Microbial infections, immunomodulation, and drugs of abuse","volume":"16","author":"Friedman","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.micinf.2017.01.002_bib7","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1136\/bmj.301.6765.1362","article-title":"Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone","volume":"301","author":"Weber","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.micinf.2017.01.002_bib8","first-page":"153","article-title":"Alterations of immune functions in heroin addicts","volume":"13","author":"Zaki","year":"2006","journal-title":"Egypt J Immunol"},{"key":"10.1016\/j.micinf.2017.01.002_bib9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0034-7094(12)70169-1","article-title":"Opioids and the immune system: clinical relevance","volume":"62","author":"Garcia","year":"2012","journal-title":"Rev Bras Anestesiol"},{"key":"10.1016\/j.micinf.2017.01.002_bib10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00005-008-0035-0","article-title":"Opiate abuse, innate immunity, and bacterial infectious diseases","volume":"56","author":"Wang","year":"2008","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.micinf.2017.01.002_bib11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1203\/01.PDR.0000074973.83826.4C","article-title":"Morphine enhances HIV infection of neonatal macrophages","volume":"54","author":"Li","year":"2003","journal-title":"Pediatr Res"},{"key":"10.1016\/j.micinf.2017.01.002_bib12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0042-6822(03)00015-1","article-title":"Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication","volume":"309","author":"Steele","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2017.01.002_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1742-4690-9-112","article-title":"Host restriction factors in retroviral infection: promises in virus-host interaction","volume":"9","author":"Zheng","year":"2012","journal-title":"Retrovirology"},{"key":"10.1016\/j.micinf.2017.01.002_bib14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fimmu.2013.00343","article-title":"Host factors and HIV-1 replication: clinical evidence and potential therapeutic approaches","volume":"4","author":"Santa-Marta","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.micinf.2017.01.002_bib15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nature00939","article-title":"Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein","volume":"418","author":"Sheehy","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2017.01.002_bib16","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nature02343","article-title":"The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys","volume":"427","author":"Stremlau","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2017.01.002_bib17","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1073\/pnas.0509996103","article-title":"Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor","volume":"103","author":"Stremlau","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micinf.2017.01.002_bib18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nm1562","article-title":"Rhesus monkey TRIM5alpha restricts HIV-1 production through rapid degradation of viral Gag polyproteins","volume":"13","author":"Sakuma","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.micinf.2017.01.002_bib19","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.bbrc.2005.10.173","article-title":"A\u00a0retrovirus restriction factor TRIM5alpha is transcriptionally regulated by interferons","volume":"338","author":"Asaoka","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.micinf.2017.01.002_bib20","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.4049\/jimmunol.177.7.4530","article-title":"STAT1-independent cell type-specific regulation of antiviral APOBEC3G by IFN-alpha","volume":"177","author":"Sarkis","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2017.01.002_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000007","article-title":"The interferon response inhibits HIV particle production by induction of TRIM22","volume":"4","author":"Barr","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.micinf.2017.01.002_bib22","doi-asserted-by":"crossref","first-page":"11513","DOI":"10.1128\/JVI.79.17.11513-11516.2005","article-title":"APOBEC3G\/CEM15 (hA3G) mRNA levels associate inversely with human immunodeficiency virus viremia","volume":"79","author":"Jin","year":"2005","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2017.01.002_bib23","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1086\/598861","article-title":"Human TRIM5alpha expression levels and reduced susceptibility to HIV-1 infection","volume":"199","author":"Sewram","year":"2009","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micinf.2017.01.002_bib24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/JVI.01810-10","article-title":"Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection","volume":"85","author":"Singh","year":"2011","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2017.01.002_bib25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/QAI.0b013e318205a59b","article-title":"An HIV-1 resistance polymorphism in TRIM5alpha gene among Chinese intravenous drug users","volume":"56","author":"Liu","year":"2011","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.micinf.2017.01.002_bib26","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1086\/520093","article-title":"Morphine inhibits intrahepatic interferon-alpha expression and enhances complete hepatitis C virus replication","volume":"196","author":"Li","year":"2007","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micinf.2017.01.002_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2008.04.026","article-title":"Morphine suppresses intracellular interferon-alpha expression in neuronal cells","volume":"199","author":"Wan","year":"2008","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.micinf.2017.01.002_bib28","doi-asserted-by":"crossref","first-page":"e31167","DOI":"10.1371\/journal.pone.0031167","article-title":"Morphine suppresses IFN signaling pathway and enhances AIDS virus infection","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2017.01.002_bib29","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/jmv.24419","article-title":"Increased expression and dysregulated association of restriction factors and type I interferon in HIV, HCV mono- and co-infected patients","volume":"88","author":"Zhu","year":"2016","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.micinf.2017.01.002_bib30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.micinf.2017.01.002_bib31","doi-asserted-by":"crossref","first-page":"e86873","DOI":"10.1371\/journal.pone.0086873","article-title":"Exploring stakeholder perceptions of facilitators and barriers to using needle exchange programs in Yunnan Province, China","volume":"9","author":"Philbin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2017.01.002_bib32","doi-asserted-by":"crossref","first-page":"e42937","DOI":"10.1371\/journal.pone.0042937","article-title":"High prevalence of HIV, HCV, HBV and co-infection and associated risk factors among injecting drug users in Yunnan province, China","volume":"7","author":"Zhou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2017.01.002_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1468-1293.2011.00940.x","article-title":"The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis","volume":"13","author":"Murray","year":"2012","journal-title":"HIV Med"},{"key":"10.1016\/j.micinf.2017.01.002_bib34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/QAI.0b013e3181967354","article-title":"Probable deceleration of progression of Simian AIDS affected by opiate dependency: studies with a rhesus macaque\/SIVsmm9 model","volume":"50","author":"Donahoe","year":"2009","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.micinf.2017.01.002_bib35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11481-009-9184-0","article-title":"Morphine and rapid disease progression in nonhuman primate model of AIDS: inverse correlation between disease progression and virus evolution","volume":"5","author":"Rivera-Amill","year":"2010","journal-title":"J\u00a0Neuroimmune Pharmacol"},{"key":"10.1016\/j.micinf.2017.01.002_bib36","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1360-0443.2009.02827.x","article-title":"Impact of injecting drug use on mortality in Danish HIV-infected patients: a nation-wide population-based cohort study","volume":"105","author":"Larsen","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.micinf.2017.01.002_bib37","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/add.12846","article-title":"Influence of different drugs on HIV risk in people who inject: systematic review and meta-analysis","volume":"110","author":"Tavitian-Exley","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.micinf.2017.01.002_bib38","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1086\/433175","article-title":"The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations","volume":"41","author":"Kapadia","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.micinf.2017.01.002_bib39","article-title":"Type I interferon at the interface of antiviral immunity and immune regulation: the curious case of HIV-1","volume":"2013","author":"Boasso","year":"2013","journal-title":"Scientifica (Cairo)"},{"issue":"Suppl. 2","key":"10.1016\/j.micinf.2017.01.002_bib40","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1097\/00002030-199311002-00012","article-title":"HIV-1 infection in the lymphoid organs","volume":"7","author":"Graziosi","year":"1993","journal-title":"AIDS"},{"key":"10.1016\/j.micinf.2017.01.002_bib41","doi-asserted-by":"crossref","first-page":"14891","DOI":"10.1074\/jbc.270.25.14891","article-title":"Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression","volume":"270","author":"Tissot","year":"1995","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.micinf.2017.01.002_bib42","doi-asserted-by":"crossref","first-page":"7828","DOI":"10.1128\/JVI.00648-11","article-title":"Modulation of TRIM5alpha activity in human cells by alternatively spliced TRIM5 isoforms","volume":"85","author":"Battivelli","year":"2011","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2017.01.002_bib43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nature09976","article-title":"TRIM5 is an innate immune sensor for the retrovirus capsid lattice","volume":"472","author":"Pertel","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2017.01.002_bib44","doi-asserted-by":"crossref","first-page":"20047","DOI":"10.1074\/jbc.R700004200","article-title":"The interferons: 50 years after their discovery, there is much more to learn","volume":"282","author":"Pestka","year":"2007","journal-title":"J\u00a0Biol Chem"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457917300047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457917300047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T17:55:33Z","timestamp":1701194133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457917300047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":44,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1286457917300047"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2017.01.002","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heroin use is associated with lower levels of restriction factors and type I interferon expression and facilitates HIV-1 replication","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2017.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Institut Pasteur. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}